Market Overview:
The global domperidone market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of gastrointestinal disorders, rising geriatric population, and growing demand for domperidone tablets, pellets, and other forms. By type, the global domperidone market is segmented into tablets, pellets, and others. The tablets segment is expected to account for the largest share of the global domperidone market in 2018. This segment is also projected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. By application, hospital pharmacies accounted for the largest share of the global domperidone market in 2017. This segment is also projected to grow at a CAGR of XX% duringthe forecast period from2018to2030.
Product Definition:
Domperidone is a drug used to increase milk production in breastfeeding mothers. It increases the release of prolactin, which is the hormone responsible for milk production. Domperidone can be taken orally or by injection, and it is available as a generic drug.
Tablets:
Tablets are small pieces of paper or plastic that contain the drug. They come in different forms such as film, oral, and effervescent. The most common type of tablet is the film-based tablet which has a diameter range from 2 to 6 mm and thickness ranging from 1 to 2 mm.
Pellets:
Pellets is the most commonly used form of Domperidone. It is a highly potent drug and has been reported to have effects similar to that of the original drug. The major advantage associated with this form of Domperidone is that it can be stored at room temperature and does not require refrigeration, which makes it more convenient for long term use.
Application Insights:
The global domperidone market is segmented by application into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacy segment dominated the overall industry in 2017 due to factors such as increasing healthcare spending and aging population. Moreover, an increase in the prevalence of chronic diseases such as heart disease, high blood pressure levels and diabetes will drive demand for domperidone from hospital pharmacists over the forecast period.
The retail pharmacy sector is expected to grow at a significant rate during the forecast period owing to rising awareness about health issues among consumers coupled with a rise in incidences of drug-related problems like adverse effects & drug resistance which require medical attention from pharmacist technicians working at retail stores. Retail stores also offer easy access to medicines through consultation with pharmacist technicians who can provide personalized advice on treatment options leading directly into purchasing decisions by customers regarding medicines required for their ailments.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to high domperidone consumption coupled with presence of a large number of key players. In addition, increasing prevalence of gastric cancer and growing geriatric population are also contributing towards growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income, improving healthcare infrastructure and rapid urbanization & industrialization in emerging countries such as China & India. Moreover, these countries have a huge demand for generic drugs due to low price-points which will further boost revenue generation over the coming years.
Growth Factors:
- Increasing prevalence of gastrointestinal disorders such as GERD, IBS, and constipation is expected to drive the demand for domperidone in the coming years.
- Rising awareness about the benefits of domperidone over other drugs is likely to boost its demand in the near future.
- Growing number of research studies on domperidone is projected to fuel its growth in the next few years.
- increasing geriatric population is anticipated to create a positive impact on the market growth during forecast period .5 Domestic production of generic versions of domperidone will further propel market growth
Scope Of The Report
Report Attributes
Report Details
Report Title
Domperidone Market Research Report
By Type
Tablets, Pellets, Other
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Schwitz Biotech, Luckys Pharma, Shreeji Pharma International, Xian Janssen Pharmaceutical, Hunan Qianjin Xiangjiang, Foshan Shouxin Pharmaceutical, Jiangxi Jiezhong Biochemistry, Meenaxy Pharma Pvt. Ltd, Hainan Asia Pharmaceutical, Lizhu Pharmaceutical Group, Jiangxi Huiren Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Domperidone Market Report Segments:
The global Domperidone market is segmented on the basis of:
Types
Tablets, Pellets, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Schwitz Biotech
- Luckys Pharma
- Shreeji Pharma International
- Xian Janssen Pharmaceutical
- Hunan Qianjin Xiangjiang
- Foshan Shouxin Pharmaceutical
- Jiangxi Jiezhong Biochemistry
- Meenaxy Pharma Pvt. Ltd
- Hainan Asia Pharmaceutical
- Lizhu Pharmaceutical Group
- Jiangxi Huiren Pharmaceutical
Highlights of The Domperidone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Pellets
- Other
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Domperidone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Domperidone is a medication used to treat nausea and vomiting. It is also used to reduce the frequency of urination.
Some of the major companies in the domperidone market are Schwitz Biotech, Luckys Pharma, Shreeji Pharma International, Xian Janssen Pharmaceutical, Hunan Qianjin Xiangjiang, Foshan Shouxin Pharmaceutical, Jiangxi Jiezhong Biochemistry, Meenaxy Pharma Pvt. Ltd, Hainan Asia Pharmaceutical, Lizhu Pharmaceutical Group, Jiangxi Huiren Pharmaceutical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Domperidone Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Domperidone Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Domperidone Market - Supply Chain
4.5. Global Domperidone Market Forecast
4.5.1. Domperidone Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Domperidone Market Size (000 Units) and Y-o-Y Growth
4.5.3. Domperidone Market Absolute $ Opportunity
5. Global Domperidone Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Domperidone Market Size and Volume Forecast by Type
5.3.1. Tablets
5.3.2. Pellets
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Domperidone Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Domperidone Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Domperidone Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Domperidone Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Domperidone Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Domperidone Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Domperidone Demand Share Forecast, 2019-2026
9. North America Domperidone Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Domperidone Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Domperidone Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Domperidone Market Size and Volume Forecast by Type
9.7.1. Tablets
9.7.2. Pellets
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Domperidone Demand Share Forecast, 2019-2026
10. Latin America Domperidone Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Domperidone Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Domperidone Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Domperidone Market Size and Volume Forecast by Type
10.7.1. Tablets
10.7.2. Pellets
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Domperidone Demand Share Forecast, 2019-2026
11. Europe Domperidone Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Domperidone Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Domperidone Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Domperidone Market Size and Volume Forecast by Type
11.7.1. Tablets
11.7.2. Pellets
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3.By Application
11.10.4. By Sales Channel
11.11. Europe Domperidone Demand Share, 2019-2026
12. Asia Pacific Domperidone Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Domperidone Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Domperidone Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Domperidone Market Size and Volume Forecast by Type
12.7.1. Tablets
12.7.2. Pellets
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Domperidone Demand Share, 2019-2026
13. Middle East & Africa Domperidone Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Domperidone Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Domperidone Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Domperidone Market Size and Volume Forecast by Type
13.7.1. Tablets
13.7.2. Pellets
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Domperidone Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Domperidone Market: Market Share Analysis
14.2. Domperidone Distributors and Customers
14.3. Domperidone Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Schwitz Biotech
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Luckys Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Shreeji Pharma International
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Xian Janssen Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Hunan Qianjin Xiangjiang
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Foshan Shouxin Pharmaceutical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Jiangxi Jiezhong Biochemistry
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Meenaxy Pharma Pvt. Ltd
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Hainan Asia Pharmaceutical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Lizhu Pharmaceutical Group
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Jiangxi Huiren Pharmaceutical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook